Back

High circulating dipeptidyl peptidase 3 is associated with cardiovascular disorders in women with postpartum haemorrhage

12 May 2024 (12:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Acute heart failure - diagnostic methods 2 Biomarkers HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Noma Assad

Inserm UMR 942- Lariboisiere hospital, Paris (France)

6 More presentations in this session

Presentation thumbnail
NT-proBNP at day 4 of hospitalization: a single prognostic marker for prediction of both in-hospital and post-discharge outcomes in acute heart failure with reduced ejection fraction
Doctor H. Hussein (Coventry, GB)
Abstract Slides Video
Presentation thumbnail
Carbohydrate antigen 125 as a biomarker for patients with acute heart failure in a nurse-based heart failure unit in a university hospital
Doctor C. Restrepo (Bogota, CO)
Abstract Slides Video
Presentation thumbnail
Predicting hospitalizations through post-discharge heart failure appointment: evaluating the FENNIX score's performance
Doctor F. Gerardo (Amadora, PT)
Abstract Slides Video
Presentation thumbnail
Prognostic value of proteinuria in patients with acute heart failure
Doctor Y. Akama (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Venous excess ultrasound (VExUS) congestion score in acute heart failure: exploring dynamic changes pre and post diuretic treatment and its correlation with prognosis, insights into potential pitfalls
Doctor F. Turrini (Carpi (MO), IT)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure - diagnostic methods 2

The Event

Event poster

Heart Failure 2024

12 May 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Exploring the relationship between obstetric complications and peripartum cardiomyopathy
thumbnail
Congress Presentation
Circulating dipeptidyl peptidase 3 levels in acute heart failure: insights from the PUSH-AHF trial
thumbnail
Congress Presentation
Guidance for women with peripartum cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources